This analysis of initial rate filings from all 50 states and DC shows ACA Marketplace insurers are proposing a median premium increase of 18% for 2026, more than double last year’s 7% median proposed increase. The analysis includes proposed rate changes by state and insurer.
Healthcare organizations must orient their models around outcomes rather than technology and capabilities alone — and that can be done through novel accountable partnerships built on a care enablement platform. The post Bringing Joy Back to Healthcare: The Power of Accountable Partnerships appeared first on MedCity News.
KFF Health News has sued the U.S. Department of Health and Human Services Office of Inspector General to compel it to release a range of Medicare Advantage health plan audits and other financial records. The suit, filed Nov. 12 in U.S. District Court in San Francisco under the Freedom of Information Act, or FOIA, seeks…
Healthcare AI customers are demanding clear, measurable ROI before they scale adoption. Here, four investors discussed how the healthcare AI startups are adapting to this new market dynamic. The post AI Startups’ ROI Reckoning: What 4 VCs Say Matters Now appeared first on MedCity News.
Obesity and diabetes drug R&D partnerships struck in 2025 represented $20.2 billion in total deal value, a new record high, according to a new report from J.P. Morgan. While IPO activity and venture investment trended downward, M&A activity was significantly higher. The post J.P. Morgan Report: Obesity & Diabetes Dealmaking Set a New Record in…
President Donald Trump’s administrations have been notorious for an array of “alternative facts” — ranging from the relatively minor (the size of inaugural crowds) to threats to U.S. democracy, such as who really won the 2020 election. And over the past six months, the stakes have been life or death: Trump’s health officials have been…
The answer to this question depends, not only on how well AI tools work, but also on how AI technologies are regulated by the FDA. Scott Gottlieb has some thoughts on preferred regulatory approaches in his recent article in JAMA Health Forum. Artificial intelligence tools with advanced analytical capabilities used in clinical practice, especially tools…
Cytokinetics drug Myqorzo won FDA approval for treating obstructive hypertrophic cardiomyopathy, or oHCM. Compared to Bristol Myers Squibb’s projected blockbuster drug Camzyos, the Cytokinetics daily pill has less restrictive safety and monitoring requirements, giving it a competitive advantage, according to analysts. The post FDA Approval Puts New Cytokinetics Heart Drug in Competition With Fast-Growing BMS…
Last summer, Lorena Alvarado Hill received a series of unexpected medical bills. A teacher’s aide in Melbourne, Florida, Hill is a single mom who works shifts at J.Crew on the weekends to send her daughter to college. Hill and her mother, who lives with her, had been enrolled in an insurance plan through HealthFirst. Hill…
Thirteen House Democrats introduced eight bills to rein in Medicare Advantage and bolster traditional Medicare. The post Lawmakers Introduce Multiple Bills Aimed at Medicare Advantage Reform appeared first on MedCity News.